DeepChek®
UltraGene®CE-IVD
UltraGene® Assay SARS-CoV-2 Universalis
SARS-CoV-2 RNA detection · 50 or 1000 tests

Overview
The UltraGene Assay SARS-CoV-2 Universalis (V2.X) is a real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2 in upper respiratory specimens from individuals suspected of COVID-19 by their healthcare provider
Specifications
Specimens
- Upper respiratory specimens (nasal, mid-turbinate, nasopharyngeal, oropharyngeal swab specimens and nasopharyngeal wash/aspirate or nasal aspirate and bronchoalveolar lavage (BAL) fluid specimens) from individuals suspected of COVID-19 by their healthcare provider
Formats
- 50 or 1000 tests per kit
- Multiplex format in 1 well per sample
Kit contents
- Master Mix 2X, RT Mix, Enzyme Mix and Magnesium Sulfate
- Specific Primers & Probes for each targeted gene: N, ORF1ab (RdRp)
- Positive control
- Negative control
- Internal control
- PCR grade nuclease-free water
Extraction
- Magnetic beads
- Validated for use with:
- Seegene STARlet instrument (Cat. #67930-03) with Hamilton Run Control software (version 4.5.0.7977)
- Seegene STARMag 96 X 4 Universal Cartridge Kit (Cat. #744300.4.UC384)
- Any laboratory validated instrument for RNA extraction and purification using magnetic-bead technology shall work
Compatible instruments
- Any qPCR instrument compatible with the FAM, HEX, ROX and Cy5 channels.
- Validated for use with:
- C1000 Dx Thermal Cycler (Bio-Rad, Catalog # 1841000-IVD with CFX96-Dx ORM software version 3.1) (C1000 CFX96),
- QuantStudio 5 Real-Time PCR Instrument (96-Well 0.1mL Block) (Applied Biosystems, Catalog #A28133, Design & Analysis Software 1.5.2 / Firmware Version 1.4.0)
Workflow
- Less than 20 minutes for up to 48 samples
- Less than 40 minutes for up to 96 samples
Performance
- Limit of detection (LOD)
- 1.15 TCID50/mL for SARS-CoV-2 with the C1000 CFX96 Dx Thermal Cycler and the QuantStudio 5 Real-Time PCR Instruments
- Clinical performance evaluation
- The positive (PPA) and negative (NPA) percent agreements between the UltraGene Assay SARS-CoV-2 Universalis V2.X and CE-IVD EUA test are for the C1000 CFX96: PPA = 28/28 = 100% (95% C.I. = 84.98% – 100%) NPA = 30/30 = 100% (95% C.I. = 85.86% – 100%)
- Clinical Accuracy
- Clinical Accuracy at 96%
Related products
UltraGene®CE-IVD
UltraGene®CE-IVD
Sample collection & equipment
